November 20th 2024
New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Symposium: Strategies to prevent multiple pregnancy during infertility treatment
February 1st 2001Pregnancies from assisted reproductive technology or ovulation induction are more likely to result in multiple birth than those conceived spontaneously. In this roundtable, a panel of experts discusses practical strategies to increase the likelihood that ART and OI/IUI will result in a singleton pregnancy.
Read More
CME: Offering mifepristone as an abortion option
February 1st 2001While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Read More
Cover Story: Antepartum and intrapartum risk factors for newborn encephalopathy
February 1st 2001Many obstetric malpractice cases focus on fixing the blame for disturbed neurological function in the first days of an infant's life. Results of recent case-control studies, described here by the authors, question the traditional thinking that most of the risk factors are in the intrapartum period.
Read More
Cover Story/Clinical Dialogue: Offering effective breastfeeding advice
August 1st 2000Breastfeeding is an area of medicine in which many obstetrician-gynecologists do not have a lot of clinical training. In this interview, we will learn how an expert in breastfeeding responds to the various clinical concerns and questions that patients bring to her. As a certified lactation consultant, Dr. Friedmann has spent considerable thought, time, and effort in ensuring the implementation and success of breastfeeding.
Read More